CEFASEPTIN300MG 100 TABS GB( CEPHALAXIN 300MG )

CEFASEPTIN300MG 100 TABS GB( CEPHALAXIN 300MG )

562.65 AED

CEFASEPTIN300MG 100 TABS GB( CEPHALAXIN 300MG )

562.65 AED

CEFASEPTIN300MG 100 TABS GB( CEPHALAXIN 300MG )

562.65 AED

Products will be delivered between 2 and 5.

0 watching this item.
0 have this item in their cart.
Product description
CEFASEPTIN 300MG 100 TABS GB (CEPHALAXIN 300MG) Cefaseptin 300 mg is a veterinary product formulated as beige, oblong, orally administered tablets, each containing 300 mg of cefalexin (as cefalexin monohydrate). It is intended for use in dogs and is available in a pack of 100 tablets (10 blisters of 10 tablets)

Key Benefits

Cefalexin is a first‑generation cephalosporin antibiotic with bactericidal activity against susceptible bacteria
Effective for treating bacterial skin infections in dogs, including superficial and deep pyoderma caused by Staphylococcus spp. sensitive to cefalexin
Also indicated for urinary tract infections in dogs, such as cystitis and nephritis, caused by cefalexin‑sensitive organisms including Escherichia coli
Tablets are scored and can be divided into two or four equal parts for flexible dosing

Composition

Active ingredient: cefalexin (as cefalexin monohydrate) 300 mg per tablet
Excipients include lactose monohydrate, povidone K30, croscarmellose sodium, microcrystalline cellulose, porcine liver powder, yeast, crospovidone, sodium stearyl fumarate

Directions for Use

Oral administration to dogs. Dosage regimen should be determined by a qualified veterinarian based on species, body weight, and clinical condition. Tablets may be divided or added to food if needed

Pack Size

Each pack contains 100 tablets, presented as 10 blisters of 10 tablets each

Note

Use only under veterinary supervision. Do not use in animals with known hypersensitivity to cephalosporins, penicillins, or any excipient. Avoid use in species such as rabbits, guinea pigs, hamsters, or gerbils. Veterinarian should consider culture and susceptibility testing or local epidemiological data when selecting therapy.